Itovebi (Inavolisib) Mechanism of Action in Treating Advanced Breast Cancer

by
a purple and black background with lots of small flowers

Itovebi is a potent kinase inhibitor that has gained attention in the treatment landscape for advanced breast cancer, particularly when used in combination with other therapeutic agents like palbociclib and fulvestrant. Its primary indication lies in targeting specific breast cancer subtypes, notably endocrine-resistant, PI3KCA-mutated, HR-positive, and HER2-negative breast cancer in adult patients. This specificity is … Read more

The Hoodie That Will Turn Heads – Spider Hoodie

by

Sp5der hoodies are functional items that can elevate any casual outfit. These hoodies can be found in numerous designs and colors, allowing you to produce diverse searches for different situations. Below are a few design tips to help you get the best from your Sp5der hoodies. Informal Appear: To get a calm, each day look, … Read more

FDA Approves Lazcluze (Lazertinib) Tablets for Non-Small Cell Lung Cancer Treatment

by
a purple and black background with lots of small flowers

Lazcluze (Lazertinib) is the latest medical breakthrough in the ongoing fight against non-small cell lung cancer (NSCLC). Officially approved by the Food and Drug Administration (FDA) on August 19, 2024, Lazcluze offers a novel therapeutic option for patients diagnosed with this aggressive and often difficult-to-treat form of cancer. Its advent marks a significant milestone in … Read more

Tecovirimat: An Effective Antiviral Treatment for Monkeypox Viral Infection

by
woman inject boy on arm

Tecovirimat, also known by its brand name Tpoxx, represents a significant milestone in antiviral drug development, specifically targeting orthopoxvirus infections such as monkeypox. Tecovirimat was formulated to inhibit the activity of a protein essential for the virus’s ability to spread from an infected cell to others, effectively halting its proliferation within the host. This innovative … Read more

Ruxolitinib Shows Dramatic Improvement for Vitiligo

by
jakaffi ruxolitinib for vitiligo

Can a new treatment change the lives of those living with vitiligo? The recent TRuE-V1 Study suggests it can. Vitiligo, a chronic skin condition that causes white patches due to pigment loss, has long had limited treatment options. A new clinical trial, the Topical Ruxolitinib Evaluation in VItiligo Study 1 (TRuE-V1), has revealed a game-changing … Read more

Mechanism of Action of Donanemab-azbt for Alzhenimer’s

by
Mechanism of Action of Donanemab kisunla old ladies taking a selfie

Donanemab got FDA approval on 2nd July 2024. The mechanism of action of Donanemab-azbt (Kisunla) is detailed here to understand how this new molecule can be a life-changer for people with Alzheimer’s disease. Kisunla (Donanemab) is a special type of medicine known as a monoclonal antibody. Monoclonal antibodies are lab-made molecules designed to fight diseases … Read more

FDA Gives a Green Signal to a New Drug for Uncomplicated UTI

by
fda approved new drug for UTI

On 24th April 2024, the FDA approves pivmecillinam under the brand name Pivya for treating uncomplicated UTIs in adult women. Uncomplicated urinary tract infections are caused by microorganisms like Staphylococcus saprophyticus, Proteus mirabilis, and Escherichia coli. The UTI infections caused by the above-mentioned bacteria are more common than others and affect almost 50% of women … Read more

What is WINREVAIR (Sotatercept-csrk)?

by
what is WINREVAIR (Sotatercept-csrk) fda approved for PAH

WINREVAIR (Sotatercept-csrk) is a recombinant activin receptor type IIA-Fc (ActRIIA-Fc) fusion protein. It blocks certain signals in the body. Specifically, it binds to and inhibits activin A and other TGF- β superfamily ligands. It corrects the imbalance between pro-proliferative (ActRIIA/Smad2/3-mediated) and anti-proliferative (BMPRII/Smad1/5/8 mediated) signaling mechanisms. By improving the bad inflammatory signals, it inhibits vascular … Read more

Daratumumab Mechanism of Action: Darzalex MOA

by
Daratumumab Mechanism of Action darzalex moa

Daratumumab Mechanism of Action: Daratumumab is a human monoclonal antibody. It is indicated for the treatment of Multiple Myeloma in the following situations: In Combination With … Daratumumab Indications Lenalidomide + dexamethasone Newly diagnosed Multiple Myeloma patients ineligible for autologous stem cell transplant OR Patients with relapsed or refractory multiple myeloma who have received at … Read more

Berdazimer Gel 10.3% (Zelsuvmi) for Molluscum Contagiosum

by
Berdazimer Gel 10.3% (Zelsuvmi) for Molluscum Contagiosum

The FDA approved Berdazimer Gel 10.3% (Zelsuvmi) for Molluscum Contagiosum on 5th January 2024. Berdazimer Gel 10.3% (Zelsuvmi) is the second topical medicine approved so far for the treatment of Molluscum Contagiosum (MC). The first one, cantharidin, was approved in 2023. Curettage is more effective than Cantharidin. However, it has not been compared with Berdazimer … Read more